Panther Fusion® AdV/hMPV/RV Assay
A fully-automated approach to respiratory testing of adenovirus (AdV), human metapneumovirus (hMPV) and rhinovirus (RV) in one single assay.1
Respiratory Testing & Patient Specific Results
Respiratory viruses are responsible for a wide range of acute respiratory tract infections including the common cold, influenza, and croup and represent a common cause of acute illness. Disease severity can be especially high in the young, the immunocompromised, and elderly patients.1
Increase Efficiency & Reduce Costs
Accurate and timely diagnosis of the cause of respiratory tract infections has a number of benefits for patients and their communities.
Reduces Complications
Helps reduce the potential for further development of antimicrobial resistance due to antibiotics.1,2
Patient Care First
Improves patient care and helps decrease costs.1-3
Results with Purpose
Provides valued information to public health authorities regarding which viruses are circulating in the community.1,4
Helps Minimise Spread
Assists infection control personnel to provide appropriate measures to minimise nosocomial spread.1,5
Simplify and Scale the Future of Diagnostics
The Panther Fusion AdV/hMPV/RV Assay is part of the Hologic Molecular Scalable Solution, a portfolio combining a broad, high-performing assay menu with high-throughput automation. Designed to flexibly scale to meet your needs, from a single patient result to population-level screening.
Be Prepared for the Winter Respiratory Season
The Panther Fusion assay shows excellent clinical performance.1
98.3% Sensitivity
97.0% specificity adenovirus
100% Sensitivity
98.6% specificity hMPV
90.1% Sensitivity
95.4% specificity RV
Right Patient. Right Test. Right Time.⁶
- From true on-demand testing to high-throughput
- No sample batch constraints, prioritise urgent samples
- First results in 2.4 hours
- Run multiple assays from a single specimen tube at the same time
- Single dose, ready-to-use-assay reagent cartridge
- Long onboard stability of fluids and reagents
Verified Sample Collection
The Panther Fusion AdV/hMPV/RV assay is validated for nasopharyngeal swabs in viral transport medium and universal transport medium.1
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
Insights
- Panther Fusion AdV/hMPV/RV Assay [package insert]. AW-29005 Rev 001. San Diego, CA: Hologic, Inc.; 2023.
- Pinsky BA, Hayden RT. Cost-Effective Respiratory Virus Testing. J Clin Microbiol. 2019 Aug 26;57(9):e00373-19. doi: 10.1128/JCM.00373-19. PMID: 31142607; PMCID: PMC6711893.
- https://www.health.vic. gov.au/health-advisories/testing-for-respiratory-pathogens Accessed August, 2022.
- WHO-2019-nCoV-Surveillance-Guidance-2022.1-eng.pdf https://apps.who.int/iris/handle/10665/351761 Accessed August, 2022.
- Lim RHF, Htun HL, Li AL, Guo H, Kyaw WM, Hein AA, Ang B, Chow A. Fending off Delta - Hospital measures to reduce nosocomial transmission of COVID-19. Int J Infect Dis. 2022 Apr;117:139-145. doi: 10.1016/j.ijid.2022.01.069. Epub 2022 Feb 4. PMID: 35124240; PMCID: PMC8813202.
- Panther/Panther Fusion System Operator´s Manual. AW-26055-001 Rev 001, San Diego, CA: Hologic Inc.; 2022.
Safety Data Sheets
Package Inserts
2797
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
Notified Body number wherever applicable
EC Representative Information wherever applicable